AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
In its ongoing attack on the safety of Quorn Foods, the Center for Science in the Public Interest dropped a new bombshell last week, claiming that Quorn's owner, Marlow Foods, may have withheld key clinical data from an expert panel charged with reviewing the products' safety.
The stinging accusation drew strong reactions from Quorn as well as UK-based Marlow, which are calling CSPI's charges "outrageous" and false. What's more, both sides had dramatically different interpretations of the study in question.
In November of last year, Marlow submitted a "generally recognized as safe" notification to FDA for Quorn products' main ingredient, a mycoprotein derived from a fungus. But CSPI claims that the British company may not have provided all of the facts to an expert panel that reviewed the scientific data supporting the GRAS notice.
In an Oct. 22 letter to the agency, CSPI said that…